Startups

Manager Equipment Service Engineering

Delfidiagnostics · Palo Alto, CA · On-site

← All jobs
About Delfidiagnostics

FirstLook Lung is a blood-based test that helps identify lung cancer risk before or alongside LDCT, for USPSTF-eligible adults. From DELFI Diagnostics. Backed by Menlo.

About the role

You will be a member of the Laboratory Operations team leading the equipment lifecycle management, service and engineering function for a variety of equipment, automation hardware, and software applications to support production in a Clinical Laboratory setting. You will provide technical and program leadership, ensuring the laboratory equipment is reliable, compliant, and appropriately supported throughout its lifecycle.

What they're looking for

  • B.S. Degree in Life Sciences, Engineering or related field
  • At least 8-10 years of combined experience in maintaining and servicing laboratory equipment in a regulated production setting
  • Experience leading equipment service, laboratory engineering, facilities/equipment, or similar technical programs, direct people-management experience strongly preferred
  • Demonstrated experience supporting high-throughput laboratory operations and complex automated laboratory systems
  • Strong knowledge of laboratory equipment lifecycle management, including installation, qualification, process validation, preventive maintenance, calibration, repair, change control, relocation, and decommissioning
  • Experience managing equipment vendors, service contracts, and external service providers
More about this role

DELFI Diagnostics, Inc. (DELFI Diagnostics) is developing next-generation, blood-based tests that are reliable, accessible and deliver a new way to help detect cancer. Employing advanced machine-learning methods to whole-genome sequencing data, the DELFI ("DNA EvaLuation of Fragments for early Interception") platform is built to address the highest-burden health challenges. DELFI Diagnostics prioritizes solutions that have the potential to save lives on a global scale, including for historically underserved populations. DELFI Diagnostics’ platform relies on fragmentomics – the discovery that cancer cells are more chaotic than normal cells and, when they die, leave behind tell-tale patterns and characteristics of cell-free DNA (cfDNA) fragments. FirstLook Lung, for individuals eligible for lung cancer screening, is DELFI Diagnostics’ first laboratory-developed screening test and can be part of routine blood work. FirstLook Lung uses millions of data points to reliably identify individuals who may have cancer detected through low-dose CT, including early stage disease with a negative predictive value of 99.8 percent. This test has not been cleared or approved by the FDA.

In our...

Read the full posting on Delfidiagnostics's site ↗

Lab Operations

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.